Helico

About:

Helico is a biopharma company.

Twitter/X: helicobio

Top Investors: Icehouse Ventures, Custos Privatstiftung, David Ross

Description:

Helico is developing a proprietary computational platform for synthetic biology research using modelling tools and AI-based prediction algorithms. The long-term aim is to develop a seed bank of different drugs able to be licensed to grow medical supplies in confined greenhouses anywhere in the world.

Total Funding Amount:

1.8M AUD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Auckland, Auckland, New Zealand

Founded Date:

2020-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-05-17

IPO Status:

Private

Industries: